Alliance A041703

A phase II study of inotuzumab ozogamicin followed by blinatumomab for Ph-negative, CD22-positive, B-lineage acute lymphoblastic leukemia in newly diagnosed older adults or adults with relapsed or refractory disease

For more information about this clinical trial, click here

Schema & Eligibility Alliance A041703

Available at:

CoxHealth Medical Center, Springfield, MO
Mercy Hospital, Springfield, MO
Delbert Day Cancer Institute at PCRMC, Rolla, MO
Freeman Health System, Joplin, MO
Good Samaritan Regional Health Center, Mt. Vernon, IL
Mercy Hospital, St. Louis, MO
Mercy South, St. Louis, MO
Mercy Hospital, Oklahoma City, OK
Mercy Hospital, Fort Smith, AK
Mercy Hospital, Joplin, MO
Mercy Clinic Cancer & Hematology, Rolla, MO
Mosaic Life Care, St. Joseph, MO

Ask your physician about participating in this clinical trial or call us.